ClinicalTrials.gov
ClinicalTrials.gov Menu

A First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2485852 in Chronically Infected Hepatitis C Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01332552
Recruitment Status : Terminated (Terminated due to unfavorable human pharmacokinetic properties)
First Posted : April 11, 2011
Last Update Posted : July 7, 2017
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : April 6, 2011
  Actual Study Completion Date : April 6, 2011